Why is DELTACON Executive Search the perfect partner for the pharmaceutical industry and the medical technology and diagnostics fields?

DELTACON Executive Search specialises in the pharmaceutical industry, and in the medical technology and diagnostics fields. 
These three disciplines all share the common feature of extremely high specialisation of companies conducting research in these sectors, as well as extremely long product cycles. It takes 10 – 15 years of intensive research and development work in the laboratory and in testing the active substance in human trials before a product can overcome the regulatory hurdles to be released onto market.

In fact, for every 5000 – 10,000 substances, just one single product will reach the market, after an average of 13.5 years! Companies have to budget for costs of 1.0 – 1.6 billion US dollars per drug with a new active substance that reaches the approval stage.

It stands to reason, then, that only companies that have sufficiently large research budgets over these protracted time periods, and who can attract the best medical professionals and scientists, will be successful in the long term.

We at DELTACON have in-depth knowledge of these issues. We can draw on many years of in-depth operational experience and guarantee our clients sound advice as well as fast and successful filling of their vacancies. In addition, we as Executive Search consultants can count on a growing network of decision-makers and candidates, facilitating quick and direct contact, and enabling us to maintain discussions on an equal footing.

Each Executive Search consultant at DELTACON is responsible for a Competence Centre, with an international scope. Our DELTACON partners have achieved great success working for countless years in leadership positions within these industries, and as a result have a nuanced understanding of the dynamics and peculiarities of the markets, the different products and the competitors, as well as the specific challenges to be expected in the sector.